Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

washingtonexaminer.com - David Harsanyi - Hate Big Pharma all you like, it still might save your life
Hate Big Pharma all you like, it still might save your life
Washington Examiner

In May, Eli Lilly announced clinical trials for a gene-editing treatment that dramatically lowers bad cholesterol, one of the primary drivers of heart disease. The technology permanently alters a gene in the liver that acts as a brake on the body's…

marketwatch.com - Jazz Pharma's Zepzelca Misses Primary Endpoint in Second-Line Lung-Cancer Trial
Jazz Pharma's Zepzelca Misses Primary Endpoint in Second-Line Lung-Cancer Trial
MarketWatch

The company said top-line results from the Phase 3 Lagoon trial of lurbinectedin, also known as Zepzelca, didn't meet its primary endpoint of overall survival when used as a monotherapy or in combination with irinotecan compared with investigators'…

globenewswire.com - Pharma Equity Group A/S - Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
GlobeNewswire

Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ('PEG' or the 'Company') today announces that it has received a final and binding…

fool.com - Alex Carchidi - Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?
The Motley Fool

Teva Pharmaceutical Industries (TEVA +0.20%) has clawed back from the brink like few drugmakers have. After a long stretch of poor performance, a company once buried under debt, patent cliffs, and litigation is now up by 97% in the last 12 months.

forbes.com - Nagesh Nama - When The Regulator Moves Faster Than The Industry It Regulates
When The Regulator Moves Faster Than The Industry It Regulates
Forbes

Nagesh Nama, CEO, xLM. Nagesh Nama is a seasoned technology executive with over 30 years of experience in life sciences. ​Something remarkable happened at a government press conference on April 28, 2026. The FDA—an agency more…

cyprus-mail.com - Cypriot pharma leader Medochemie celebrates five decades of expansion
Cypriot pharma leader Medochemie celebrates five decades of expansion
Cyprus Mail

Medochemie marked its 50th anniversary in 2026, reflecting on a journey that transformed a Limassol-based start-up into a global pharmaceutical exporter built on vision, innovation and sustained international expansion. Behind five decades of…

marketbeat.com - Castleark Management LLC Increases Position in Ascendis Pharma A/S $ASND
Castleark Management LLC Increases Position in Ascendis Pharma A/S $ASND
MarketBeat

Castleark Management LLC increased its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 55.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned…

marketbeat.com - Ascendis Pharma A/S $ASND Shares Sold by Sector Gamma AS
Ascendis Pharma A/S $ASND Shares Sold by Sector Gamma AS
MarketBeat

Sector Gamma AS trimmed its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 33.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned…

marketbeat.com - Monashee Investment Management LLC Sells 100,000 Shares of BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC Sells 100,000 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Monashee Investment Management LLC cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange…

nymag.com - Matt Stieb - I Figured Out How to Rig Rotten Tomatoes Prediction Markets
I Figured Out How to Rig Rotten Tomatoes Prediction Markets
New York Magazine

Insider trading used to be the domain of mergers and acquisitions lawyers, bankers in contrast collars, and Martha Stewart — people with influence using tips from their station in life to win while people on the outside lost. But the game…

marketbeat.com - Teva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by Clal Insurance Enterprises Holdings Ltd
Teva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by Clal Insurance Enterprises Holdings Ltd
MarketBeat

Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and…

bleepingcomputer.com - Lawrence Abrams - Maine disables data breach notification portal after fake disclosures
Maine disables data breach notification portal after fake disclosures
BleepingComputer

Maine has taken its public data breach reporting portal offline after fraudulent breach disclosures were published on the state's website, prompting a review of procedures to prevent abuse in the future. Yesterday, BleepingComputer reported that…

politico.eu - Shawn Pogatchnik - Canada's Carney heads to Ireland, where keeping Trump happy comes first
Canada's Carney heads to Ireland, where keeping Trump happy comes first
POLITICO

“We will be resolutely and sincerely pro-Canada. We will just as resolutely avoid saying a syllable that might be construed in any way as critical of Donald Trump or his administration,” an Irish government official helping to plan…

marketbeat.com - AbbVie Inc. $ABBV Shares Sold by Sepio Capital LP
AbbVie Inc. $ABBV Shares Sold by Sepio Capital LP
MarketBeat

Sepio Capital LP lessened its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned…

thehindubusinessline.com - KS Badri Narayanan - Stock Market Highlights, June 12: Sensex, Nifty surge nearly 2% as falling oil prices lift market sentiment
Stock Market Highlights, June 12: Sensex, Nifty surge nearly 2% as falling oil prices lift market sentiment
BusinessLine

Sensex Today, Nifty 50 | Stock Market Highlights - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 12th June 2026 Sensex closed 1,695 points higher at 75,527, while the Nifty gained 461…

Receive a Daily briefing on Pharma Industry News

Get Started